Hypoxia is an important form of physiological stress that induces cell death, due to the resulting endoplasmic reticulum (ER) stress, particularly in solid tumors. Although previous studies have indicated that cyclophilin B (CypB) plays a role in ER stress, there is currently no direct information supporting the mechanism of CypB involvement under hypoxic conditions. However, it has previously been demonstrated that ER stress positively regulates the expression of CypB. In the present study, it was demonstrated that CypB is transcriptionally regulated by hypoxia-mediated activation of transcription factor 6 (ATF6), an ER stress transcription factor. Subsequently, the effects of ATF6 on CypB promoter activity were investigated and an ATF6-responsive region in the promoter was identified. Hypoxia and ATF6 expression each increased CypB promoter activity. Collectively, these results demonstrate that ATF6 positively regulates the expression of CypB by binding to an ATF6-responsive region in the promoter, which may play an important role in the attenuation of apoptosis in the adaption to hypoxia. These results suggest that CypB may be a key molecule in the adaptation of cells to hypoxic conditions.
Introduction
An immediate reaction to hypoxia is a reduction in the rate of global protein synthesis, which is thought to reduce energy demands when oxygen and adenosine triphosphate levels are low (1) . This response triggers stressors that alter the environment of the endoplasmic reticulum (ER) by impairing nascent ER protein glycosylation, disulfide bond formation or calcium level interference with protein folding, resulting in the ER stress response (2) (3) (4) . To prevent the deleterious effects of ER stress, cells have evolved numerous protective strategies, including activating signal transduction pathways that trigger complex transcriptional and translational responses, which is known as the unfolded protein response (UPR) (5) . The UPR is mediated by three distinct ER-transmembrane signaling proteins that act as major proximal sensors of the ER stress response, consisting of inositol-requiring transmembrane kinase and endonuclease 1α, activation of transcription factor 6 (ATF6) and protein kinase-like ER kinase (6) (7) (8) . Full-length p90-ATF6 is located in the ER membrane, and in the absence of ER stressors, the protein is maintained in an inactive form by binding to glucose-regulated protein (GRP)78 (9) . When activated, cleaved ATF6, or p50-ATF6, then translocates into the nucleus, where it activates the transcription of ER stress response-associated genes, including GRP78 (10, 11) .
Cyclophilin B (CypB) is a 21-kDa protein belonging to the cyclophilin family of peptidyl-prolyl cis-trans isomerases (12) . CypB has been identified in the ER and nucleus and is also present in notable levels in the blood and breast milk (13) . It has previously been revealed that CypB plays important roles in the response to ER stress-mediated cell death (14) . Although it has been reported that the expression of CypB is regulated under physiological and pathophysiological states, the mechanism of the regulation is largely unknown.
The aim of the present study was to explore the possible functional mechanisms underlying the induction of CypB under hypoxic conditions. In addition, the transcription factors involved in the increase of CypB expression under hypoxia have yet to be reported in the literature. In the present study, it was demonstrated that hypoxia transcriptionally upregulates CypB through ATF6. Therefore, understanding the molecular basis of the regulation of CypB under hypoxic conditions is of clinical importance for the removal of gastric adenocarcinoma cells. These results indicate that CypB may be a key molecule in the adaptation of cells to hypoxia. ) . Cultured AGS cells were subjected to hypoxic conditions at 37˚C for the time periods indicated, while controls were maintained in normoxic conditions at 37˚C for the same time periods.
Meterials and methods

Reagents
Reverse transcription-polymerase chain reaction (RT-PCR)
and quantitative PCR analysis. Total cellular RNA was extracted from cells using TRIzol reagent (Invitrogen). The cDNA was synthesized from 1 µg of total RNA using M-MLV reverse transcriptase (Fermentas, Hanover, MD, USA). The specific primers used for RT-PCR are as follows: CypB forward, 5'-AATTCCATCGTGTAATCAAGGACTT-3' and reverse, 5'-TCTTGACTGTCGTGATGAAGAACT-3'; and β-actin forward, 5'-GTACTTGCGCTCAGGAGGAG-3' and reverse, 5'-TCGTGCGTGACATTAAGGGG-3'. The PCR products were analyzed by agarose gel electrophoresis and visualized using ethidium bromide. The signals were quantitated using ImageJ software (version 1.45; National Institutes of Health, Bethesda, MD, USA). Quantitative PCR was performed using an ABI prism 7300 Sequence Detection System (Applied Biosystems Life Technologies, Foster City, CA, USA) with SYBRGreen PCR Master Mix (Applied Biosystems). The PCR reaction was carried out for 40 thermal cycles of denaturation at 94˚C for 30 sec, annealing at 55˚C for 30 sec and extension at 72˚C for 30 sec. Expression of the target gene was analyzed by an absolute quantification method and normalized using β-actin levels.
Luciferase assay. The CypB promoter sequence was analyzed using Genomatix MatInspector (Genomatix Software GmbH, Munich, Germany). One ER stress element (ERSE) candidate was located at 222 bp, ~209 bp from the CypB open reading frame. The AGS cells were transfected with 1.0 µg of the pGL3 basic-derived plasmids together with the pCMV-β-galactosidase internal control plasmid (Promega, Madison, WI, USA). The activity of luciferase and β-galactosidase was measured using 50 µl of each cell lysate and a fluorescence microplate reader (Victor 1420 Multilabel Counter; Wallac, Turku, Finland). The luciferase activity was normalized on the basis of the β-galactosidase values. The transfection experiments were performed in triplicate and repeated at least three times.
Western blot analysis. The cells were washed twice with cold PBS on ice and harvested by scraping with a rubber cell scraper. The cells were pelleted by centrifugation at 4˚C and resuspended directly into a lysis buffer, which consisted of 50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1% Triton X-100, 0.5% Igepal CA-630, 2 mM EDTA, 10 mM NaF, 2 mM Na 3 VO 4 and 0.01% protease inhibitor cocktail. The cell lysates were subjected to SDS-PAGE and transferred to a nitrocellulose membrane. Subsequent to blocking in 5% skim milk and Tris-buffered saline with 0.1% Tween-20, signals were detected and analyzed by a Kodak X-OMAT 2000 image analyzer. Densitometric analysis was performed using ImageJ software.
Statistical analysis. The results were expressed as the mean ± standard deviation, which was obtained from at least three independent experiments. Statistical analyses were conducted using a Student's t-test. By convention, P<0.05 was considered to indicate a statistically significant difference.
Results
Hypoxia results in the transcriptional upregulation of CypB expression. Since overexpression of CypB has been demonstrated in numerous types of cancer cells, the present study investigated whether the elevated CypB level is caused by transcriptional induction. RT-PCR was performed using AGS cells that were subjected to hypoxic conditions for 0, 6 and 18 h (Fig. 1A) . Upregulated CypB mRNA expression was observed during a 6 h exposure to hypoxia, and up to a five-fold increase in CypB mRNA expression was identified in the cells exposed to an 18 h period of hypoxia, compared with the negative control. In addition, the treatment of AGS cells with 5 µg/ml actinomycin D, an mRNA synthesis inhibitor, abolished the hypoxia-mediated induction of CypB mRNA expression, indicating that upregulated CypB mRNA is mainly induced, not by mRNA stability, but by the de novo synthesis of mRNA under hypoxia. The quantitative PCR also demonstrated upregulated CypB mRNA levels under hypoxia, consistent with the results shown in Fig. 1A and B. To further understand the molecular mechanisms by which CypB mRNA is induced by hypoxia, the CypB promoter activity was monitored using the wild-type CypB-974 promoter in AGS cells (Fig. 1C) . As expected, the luciferase activity of the wild-type CypB-974 promoter also demonstrated a significant increase under hypoxic conditions compared with normoxic conditions. These results indicate that the CypB gene is transcriptionally induced under hypoxic conditions in AGS cells.
The CypB protein level was subsequently monitored in AGS cells under hypoxic conditions, and it was found that CypB protein expression was significantly increased (Fig. 1D) . A time-course experiment demonstrated that CypB protein expression under hypoxic conditions reached a maximum level after 6 h and was sustained until the cells had been exposed to hypoxia for 18 h. Densitometric analysis revealed that the CypB protein expression was higher in AGS cells exposed to hypoxic conditions when compared with the control, suggesting a crucial role of CypB in hypoxia. These results indicate that CypB expression is upregulated by hypoxia in AGS cells.
Hypoxia-mediated induction of CypB requires an ATF6 transcription factor. The promoters of ER chaperones contain
ERSEs (10, 15) and previous studies have revealed that the human CypB promoter contains ER stress-responsive elements that are induced by ATF6-dependent pathways (16) . To identify the region of the CypB promoter that is responsible for hypoxia-induced transcriptional upregulation, the luciferase activity was measured using incrementally truncated reporter plasmids, comprising pGL3-CypB-974, -800, -350, -250 and -100, that were transfected into AGS cells (Fig. 2A) . The luciferase activity in each assay was normalized to that of a co-transfected pGL3-basic plasmid, pCMV-β-galactosidase luciferase. The pCMV-β-galactosidase luciferase plasmid did not respond to hypoxia, but the pGL3-CypB-250, -350, -800 and -974 reporter plasmids demonstrated significantly increased luciferase activity under hypoxic conditions. The empty pGL3-basic vector and pGL3-CypB-100 plasmid did not demonstrate hypoxia-induced luciferase activity. These results suggest that the cis-element responsible for the response to hypoxic conditions is within the region 250 bp upstream of the transcription start site. Within this region, the ERSE element was located using a promoter analysis program. Therefore, it was hypothesized that the ERSE element is associated with hypoxia-induced transcription activity. In the following promoter experiments, pGL3-CypB-250, a plasmid containing the ERSE element of the CypB promoter, was used to test this hypothesis in detail. 
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ATF6 is a UPR transducer that binds to the CCACG region of ERSE elements in the promoter region of UPR-responsive genes (15) . ATF6 is constitutively synthesized as a 90-kDa protein, termed p90ATF6, that is converted to a 50-kDa protein, termed p50ATF6, particularly in ER-stressed cells prior to the induction of GRP78. p50ATF6 translocates into the nucleus, where it specifically activates the transcription of ER stress response-associated genes, including GRP78 (17) . To determine whether CypB is regulated by p50ATF6 at the transcriptional level under hypoxic conditions, the AGS cells were transiently co-transfected with ATF6 transcription factor expression plasmids and pGL3-CypB-250 plasmids. The luciferase activity of these transfected cells was subsequently analyzed (Fig. 2B) . It was found that p50ATF6 expression plasmids increased the luciferase activity in the transfected cells compared with cells transfected with the pcDNA3 empty vector. RT-PCR and western blot analysis revealed that CypB protein expression is increased by the expression of p50ATF6 in AGS cells (Fig. 2C) . These results indicate that the hypoxia-mediated activation of CypB transcription requires ATF6.
Discussion
In the present study, the ER stress-mediated ATF6 pathway of CypB expression was demonstrated to be one of the mechanisms induced by hypoxia in AGS cells. It has previously been reported that CypB activation was found to protect AGS cells against hypoxia through the attenuation of ER stress-mediated cell death. However, the mechanism for the induction of the ER stress pathways following exposure to hypoxia have not been clearly identified.
In the present study, ATF6, an ER stress-associated transcription factor, was found to mediate the upregulation of CypB under hypoxic conditions (Fig. 1) . ERSE, ERSE-II and ATF6-binding cis-acting element have been reported as consensus sequences for the binding of p50ATF6 (15, 18, 19) . The ER stress response element CCAAT-N9-gtaaCGTGG (ERSE-III), which is located within the CypB promoter region and is similar to the conventional ERSE-I motif of CCAAT-N9-CCACG (19) , was consistently used for ATF6 binding under hypoxic conditions, as demonstrated by the luciferase assay. Hypoxia was found to significantly upregulate CypB mRNA expression in a time-dependent and ATF6-dependent manner. The stimulation of ERSE-mediated transcription activity by ATF6 requires the integrity of the tripartite structure of the ERSE, a high-affinity CCAAT binding site for NF-Y/CBF and a functional NF-Y complex, which is consistent with the present results.
It has been established that ER stress favors survival and induces apoptotic signaling in various types of cells. Therefore, the decision between survival and apoptosis may depend on the 
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balance between survival signaling and apoptotic signaling. In future studies, the involvement of ER stress-specific apoptotic signaling in hypoxia in AGS cells may be examined. In summary, ATF6 upregulates CypB gene expression through an increase in the promoter activity of CypB in AGS cells, which may demonstrate anti-apoptotic properties under hypoxic conditions. Future studies investigating the mechanism through which CypB prevents ER stress may aid the present understanding of the nature of hypoxia-associated diseases, including solid tumors.
